[Table/Fig-1]:
Antimicrobial agents | Nath G et al.,2000 | Pratap CB et al.,2012 | This study | ||
---|---|---|---|---|---|
1979-1989 n=44(%) | 1990-1998 n=96(%) | 1998-1999 n=22 (%) | 2009-2010 n=36(%) | 2011-2013 n=47(%) | |
Nalidixic acid (NA) | nd* | nd | nd | nd | 36 (76.6) |
Amoxicillin (AMC) | 20 (45.4) | 46 (47.9) | 8 (36.4) | 21 (58.3) | 18 (38.3) |
Cephalexin (CP) | 24 (54.5) | 60 (62.5) | 10 (45.4) | nd | 13 (27.6) |
Cefuroxime (CXM) | 4 (9.0) | 12 (12.5) | 2 (9.0) | 8 (22.2) | 13 (27.6) |
Ciprofloxacin (CIP) | 3 (6.8) | 00 | 00 | 7 (19.4) | 12 (25.5) |
Ceftriaxone (CTR) | 2 (4.5) | 2 (2.1) | 00 | 6 (16.7) | 11 (23.4) |
Cefoxitin (CX) | nd | nd | nd | nd | 10 (21.3) |
Azithromycin (AZM) | nd | nd | nd | nd | 10 (21.3) |
Co-Trimoxazole (COT) | 18 (40.9) | 38 (39.5) | 2 (9.0) | 10 (27.8) | 9 (19.1) |
Imipenem (I) | nd | nd | nd | nd | 4 (8.5) |
Chloramphenicol (C) | 22 (50) | 52 (54.2) | 7 (31.8) | 9 (25) | 1 (2.1) |
nd=Not determined.